Q2 2025 Holdings
Filed 2025-08-14 | 11 holdings | $299.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Beam Therapeutics Inc.(BEAM) | COM | 07373V105 | $77.2M | 4,540,132 | 25.8% |
| VIR Biotechnology Inc.(VIR) | COM | 92764N102 | $65.1M | 12,916,663 | 21.8% |
| Maze Therapeutics Inc.(MAZE) | COM | 578784100 | $50.6M | 4,120,053 | 16.9% |
| Rapport Therapeutics Inc.(RAPP) | COM | 75383L102 | $42.4M | 3,728,738 | 14.2% |
| Verve Therapeutics Inc. | COM | 92539P101 | $22.6M | 2,008,809 | 7.5% |
| Lyell Immunopharma Inc.(LYEL) | COM NEW | 55083R203 | $16.1M | 1,820,634 | 5.4% |
| Erasca Inc.(ERAS) | COM | 29479A108 | $14.1M | 11,055,554 | 4.7% |
| Gossamer BIO Inc.(GOSS) | COM | 38341P102 | $9.9M | 8,055,916 | 3.3% |
| Q32 BIO Inc.(QTTB) | COM | 746964105 | $477.5K | 320,482 | 0.2% |
| Unity Biotechnology Inc.(UNBX) | COM NEW | 91381U200 | $386.0K | 1,004,817 | 0.1% |
| Cero Therapeutics Holdings Inc.(CERO) | COM | 71902K402 | $215.6K | 22,389 | 0.1% |